UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

The New England journal of medicine, 2022-03, Vol.386 (12), p.1143-1154

2022

Volltextzugriff (PDF)

Computational studies of polyurethanases from Pseudomonas

Journal of molecular modeling, 2021-01, Vol.27 (2), p.46-46, Article 46

2021

Volltextzugriff (PDF)

Abstract PS16-34: Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS16-34-PS16-34

Petry, Vanessa

2021

Volltextzugriff (PDF)

Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: Evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO

Bioorganic & medicinal chemistry, 2011-12, Vol.19 (24), p.7416-7424

2011

Volltextzugriff (PDF)

Return to work after breast cancer diagnosis: An observational prospective study in Brazil

Cancer, 2018-12, Vol.124 (24), p.4700-4710

2018

Volltextzugriff (PDF)

A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53)

Breast (Edinburgh), 2023-04, Vol.68, p.157-162

2023

Volltextzugriff (PDF)

Patterns of genetic diversity, spatial genetic structure and gene flow in Campomanesia xanthocarpa: insights from SSR markers of different genomic origins

Anais da Academia Brasileira de Ciências, 2021-01, Vol.93 (suppl 3), p.e20210134-e20210134

2021

Volltextzugriff (PDF)

Influence of a Training Session on Postural Stability and Foot Loading Patterns in Soccer Players

Orthopedic Reviews, 2016-03, Vol.8 (1), p.6360-6360

2016

Volltextzugriff (PDF)

Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis

Anais brasileiros de dermatología, 2016-09, Vol.91 (5), p.604-610

2016

Volltextzugriff (PDF)

Repetitive genomic elements in Campomanesia xanthocarpa: prospection, characterization and cross amplification of molecular markers

3 Biotech, 2019-11, Vol.9 (11), p.1-11, Article 423

2019

Volltextzugriff (PDF)

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy

Biomarker research, 2018-06, Vol.6 (1), p.20-20, Article 20

2018

Volltextzugriff (PDF)

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

The New England journal of medicine, 2022-03, Vol.386 (12), p.1143-1154

2022

Volltextzugriff (PDF)

Polyurethanases: Three-dimensional structures and molecular dynamics simulations of enzymes that degrade polyurethane

Journal of molecular graphics & modelling, 2019-06, Vol.89, p.82-95

2019

Volltextzugriff (PDF)

Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance

Neuroendocrinology, 2018-01, Vol.106 (1), p.30-37

2018

Volltextzugriff (PDF)

Colonization by S. Aureusincreases the EASI and the number of appointments by patients with atopic dermatitis: cohort with 93 patients

Anais brasileiros de dermatología, 2013-08, Vol.88 (4), p.518-521

2013

Volltextzugriff (PDF)

Characterization of Phenotypic Diversity of Feijoa Fruits of Germplasm Accessions in Brazil

Agrosystems, geosciences & environment, 2019-01, Vol.2 (1), p.1-11

2019

Volltextzugriff (PDF)

Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique

International journal of radiation oncology, biology, physics, 2024-07, Vol.119 (4), p.1086-1091

2024

Volltextzugriff (PDF)

Trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (pts) with HER2-positive (HER2+) unresectable and/or metastatic breast cancer (mBC): Safety follow-up of the randomized, phase 3 study DESTINY-Breast03

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1000-1000

2022

Volltextzugriff (PDF)

Abstract GS3-01: Trastuzumab deruxtecan (T-DXd; DS-8201a) vs. trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (mBC): subgroup analyses from the randomized phase 3 study DESTINY-Breast03

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS3-01-GS3-01

2022

Volltextzugriff (PDF)

Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience

Breast care (Basel, Switzerland), 2014-04, Vol.9 (4), p.255-260

2014

Volltextzugriff (PDF)

Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation

The Journal of steroid biochemistry and molecular biology, 2019-06, Vol.190, p.250-255

2019

Volltextzugriff (PDF)

FRI256 The Clinical Impacts Of Bi-allelic Germline Pathogenic Variant In TP53 In Two Patients With Li-Fraumeni Syndrome

Journal of the Endocrine Society, 2023-10, Vol.7 (Supplement_1)

2023

Volltextzugriff (PDF)

Patterns of genetic diversity, spatial genetic structure and gene flow in Campomanesia xanthocarpa: insights from SSR markers of different genomic origins

Anais da Academia Brasileira de Ciências, 2021, Vol.93 (suppl 3)

2021

Volltextzugriff (PDF)

Abstract P3-05-12: A matched cohort study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-05-12

2023

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(74)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

Computational studies of polyurethanases from Pseudomonas

Abstract PS16-34: Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants

Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: Evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO

Return to work after breast cancer diagnosis: An observational prospective study in Brazil

A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53)

Patterns of genetic diversity, spatial genetic structure and gene flow in Campomanesia xanthocarpa: insights from SSR markers of different genomic origins

Influence of a Training Session on Postural Stability and Foot Loading Patterns in Soccer Players

Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis

Repetitive genomic elements in Campomanesia xanthocarpa: prospection, characterization and cross amplification of molecular markers

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Polyurethanases: Three-dimensional structures and molecular dynamics simulations of enzymes that degrade polyurethane

Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance

Colonization by S. Aureusincreases the EASI and the number of appointments by patients with atopic dermatitis: cohort with 93 patients

Characterization of Phenotypic Diversity of Feijoa Fruits of Germplasm Accessions in Brazil

Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique

Trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (pts) with HER2-positive (HER2+) unresectable and/or metastatic breast cancer (mBC): Safety follow-up of the randomized, phase 3 study DESTINY-Breast03

Abstract GS3-01: Trastuzumab deruxtecan (T-DXd; DS-8201a) vs. trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (mBC): subgroup analyses from the randomized phase 3 study DESTINY-Breast03

Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience

Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation

FRI256 The Clinical Impacts Of Bi-allelic Germline Pathogenic Variant In TP53 In Two Patients With Li-Fraumeni Syndrome

Patterns of genetic diversity, spatial genetic structure and gene flow in Campomanesia xanthocarpa: insights from SSR markers of different genomic origins

Abstract P3-05-12: A matched cohort study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome

Suchergebnisse filtern